Treating uveitis via Triesence injections

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Can TRIESENCE® Injections be Used to Treat Uveitis?

Posted By Dr. Ari Weitzner On February 20, 2013 @ 7:08 am In Clinical Trials,New Technologies,Uveitis | Comments Disabled

In a recently commenced clinical trial, Clearside Biomedical, Inc. will be evaluating the effectiveness of treating uveitis by injecting TRIESENCE® (triamcinolone acetonide injectable suspension 40 mg/mL) in a total volume of 100 uL directly into the eye’s suprachoroidal space (SCS) via Clearside’s proprietary microneedle.

Clearside’s patented microinjection system is the only non-surgical application to introduce drugs into targeted eye tissue at the back of the eye via the SCS.

Click here ^[1] for further details about this clinical trial.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/007048-can-triesence-injections-be-used-to-treat-uveitis/

URLs in this post:

[1] Click here: http://www.clinicaltrials.gov/ct2/show/record/NCT01789320

Click here to print.